Genedx Holdings (WGS) | Stock Overview & Key Data
Genedx Holdings Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $417.42 on August 9, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Genedx Holdings
WGS
|
1.94B Small-cap | 18.38% | 50.48% | -19.43% | -59.29% | -53.65% | -7.20% | 793.00% | 332.95% | 511.43% | 511.43% | 511.43% |
|
Thermo Fisher
TMO
|
174.55B Large-cap | 0.87% | 8.07% | 0.79% | -17.74% | -20.05% | 16.53% | -12.65% | -2.72% | 220.94% | 654.32% | 1,231.84% |
|
Danaher
DHR
|
126.39B Large-cap | -1.32% | 11.85% | -5.38% | -20.75% | -21.40% | -10.25% | -15.98% | -20.94% | 174.08% | 416.93% | 738.84% |
|
CareDx
CDNA
|
1.09B Small-cap | 9.70% | 20.58% | 39.03% | 20.94% | 25.81% | 23.56% | 188.57% | -74.09% | 348.63% | 129.70% | 129.70% |
|
NeoGenomics
NEO
|
1.03B Small-cap | 1.28% | 34.59% | 34.59% | -6.96% | -5.70% | 57.71% | -33.31% | -74.14% | 39.90% | 751.15% | 1,822.41% |
|
Opko Health
OPK
|
936.60M Small-cap | -2.10% | 27.27% | 17.65% | 3.70% | 10.24% | 6.77% | -8.39% | -61.62% | -84.31% | -56.84% | 246.34% |
Ownership & Short Interest
Calculate Your Genedx Holdings Investment Returns
Long-Term Investment Performance Analysis
Genedx Holdings stock price in Nov 2020 was $9.80, A $1,000.00 lump sum investment in Genedx Holdings made 5 years ago would be worth approximately $6,257.14 today, representing a exceptional return of 525.71%. This translates to an annualized return (CAGR) of 38.62%.
5 Years 7 Months Investment Scenario (Nov 2020 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is WGS's 52-week high and low?
- In the last 52 weeks, Genedx Holdings reached a high of $170.87 (on December 2, 2025) and a low of $32.21 (on May 6, 2026).
- What is the market cap and P/E ratio for WGS?
- Curious about Genedx Holdings's size and valuation? Its market capitalization stands at 1.94B. When it comes to valuation, the P/E ratio (trailing twelve months) is 724.64, and the forward P/E (looking ahead) is 33.95.
- Does WGS pay dividends? If so, what's the yield?
- As for dividends, Genedx Holdings isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Genedx Holdings's main competitors or similar companies to consider before investing?
When looking at Genedx Holdings, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Thermo Fisher
TMO174.55B Healthcare Diagnostics & Research 16.53% -12.65% Danaher
DHR126.39B Healthcare Diagnostics & Research -10.25% -15.98% CareDx
CDNA1.09B Healthcare Diagnostics & Research 23.56% 188.57% NeoGenomics
NEO1.03B Healthcare Diagnostics & Research 57.71% -33.31% Opko Health
OPK936.60M Healthcare Diagnostics & Research 6.77% -8.39% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Genedx Holdings Corp? (e.g., ROE, Debt/Equity)
- To get a sense of Genedx Holdings's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -7.60%, the Debt to Equity ratio from the most recent quarter is 36.72, and its Gross Profit Margin stands at 69.65%.
- What is the recent revenue and earnings growth for WGS?
- Looking at Genedx Holdings's growth, its revenue over the trailing twelve months (TTM) was $428M. Compared to the same quarter last year (YoY), quarterly revenue grew by 26.50%, and quarterly earnings saw a YoY growth of 26.50%.
- How much of WGS stock is held by insiders and institutions?
- Wondering who owns Genedx Holdings stock? Company insiders (like executives and directors) hold about 12.56% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 104.86%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.